Investor News

Get News Alerts by Email

  • Medicure Announces Normal Course Issuer Bid

    Monday, June 29, 2020

    View article

  • Medicure Announces Positive Results for AGGRASTAT® in the FABOLUS-FASTER Trial and Publication in the Journal - Circulation

    Monday, June 29, 2020

    View article

  • Medicure Announces a Direct to Patient Online Pharmacy Program for Distribution of ZYPITAMAG™ (Pitavastatin) Tablets

    Thursday, June 25, 2020

    View article

  • Medicure Announces Top Line Data from FABOLUS-FASTER Trial With AGGRASTAT® will be Presented at the PCR e-Course, Late Breaking Trial Sessions, June 27, 2020

    Monday, June 15, 2020

    View article

  • Medicure Reports Financial Results for Quarter Ended March 31, 2020

    Tuesday, May 12, 2020

    View article

  • Medicure Q1 2020 results and conference call dates

    Wednesday, May 6, 2020

    View article

  • Medicure Reports Financial Results for Quarter and Year Ended December 31, 2019

    Wednesday, April 15, 2020

    View article

  • Medicure To Announce Fiscal Year End 2019 Financial Results on April 15, 2020

    Monday, April 13, 2020

    View article

  • Medicure Announces Preliminary Results of Substantial Issuer Bid

    Friday, December 20, 2019

    View article

  • Medicure Announces the Completion of Shortened AGGRASTAT® Versus Integrilin® in Percutaneous Coronary Intervention (SAVI-PCI) Study

    Tuesday, December 17, 2019

    View article

  • Medicure Announces Completion of Enrollment for FABOLUS-FASTER, Phase 4 Clinical Trial of Aggrastat (Tirofiban Hydrochloride) Injection VS Kengreal (Cangrelor) in Patients Undergoing Percutaneous Coronary Intervention (PCI)

    Thursday, December 12, 2019

    View article

  • Medicure Announces Settlement of Holdback Dispute from Apicore Sale

    Thursday, December 5, 2019

    View article

  • Medicure Files Patent Infringement Action

    Thursday, December 5, 2019

    View article

  • Medicure Reports Financial Results for Quarter Ended September 30, 2019

    Tuesday, November 26, 2019

    View article

  • Medicure Q3 2019 Results and Conference Call Dates

    Tuesday, November 19, 2019

    View article

  • Medicure Announces Commencement of Substantial Issuer Bid

    Wednesday, November 13, 2019

    View article

  • Medicure Announces Intention to Commence Substantial Issuer Bid

    Monday, November 4, 2019

    View article

  • Medicure Announces SMILE™-HF Study Demonstrates Use of ReDS™ Results in 58% Reduction in Hospital Readmission Rate

    Tuesday, October 15, 2019

    View article

  • Medicure Announces Preferred Pricing Agreement for Zypitamag™ with the AIDS Drug Assistance Program ("ADAP") Crisis Task Force

    Thursday, October 3, 2019

    View article

  • Medicure Announces Acquisition Of Full United States Ownership Of Zypitamag™

    Monday, September 30, 2019

    View article

  • Medicure Announces Launch of New and Improved ReDS™ PRO

    Tuesday, September 17, 2019

    View article

  • Medicure Announces Settlement of Patent Infringement Action

    Wednesday, August 21, 2019

    View article

  • Medicure Reports Financial Results for Quarter Ended June 30, 2019

    Thursday, August 8, 2019

    View article

  • Medicure Q2 2019 Results and Conference Call Dates

    Friday, August 2, 2019

    View article

  • Medicure Announces Results of 2019 Annual Meeting of Shareholders

    Wednesday, June 26, 2019

    View article

  • Medicure Announces Appoinment of Dr. Neil Owens as President and Chief Operating Officer

    Monday, June 10, 2019

    View article

  • Medicure Announces Renewal of its Normal Course Issuer Bid

    Thursday, May 30, 2019

    View article

  • Medicure Reports Financial Results for Quarter Ended March 31, 2019

    Monday, May 27, 2019

    View article

  • Medicure Q1 2019 Results and Conference Call Dates

    Wednesday, May 22, 2019

    View article

  • Medicure Appoints Ms. Manon Harvey to its Board of Directors

    Wednesday, May 15, 2019

    View article

  • Medicure Reports Financial Results for Quarter and Year Ended December 31, 2018

    Monday, April 29, 2019

    View article

  • Medicure to Announce Fiscal Year End 2018 Financial Results on April 29, 2019

    Wednesday, April 24, 2019

    View article

  • Medicure Provides Update on Release of Holdback Funds from Apicore Sale

    Wednesday, February 13, 2019

    View article

  • Medicure Announces Agreement to Market ReDS™ Device for Congestive Heart Failure Patients in the United States

    Monday, January 28, 2019

    View article

  • Medicure reports financial results for quarter ended September 30, 2018

    Tuesday, November 20, 2018

    View article

  • Medicure Files Patent Infringement Action

    Friday, November 16, 2018

    View article

  • Medicure Q3 2018 Results and Conference Call Dates

    Wednesday, November 14, 2018

    View article

  • Medicure Reports Financial Results for Quarter Ended June 30, 2018

    Wednesday, August 15, 2018

    View article

  • Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection

    Monday, August 13, 2018

    View article

  • Medicure Q2 2018 Results and Conference Call Dates

    Wednesday, August 8, 2018

    View article

  • Medicure Reports Financial Results for Quarter Ended March 31, 2018

    Wednesday, May 23, 2018

    View article

  • Medicure Q1 2018 Results and Conference Call Dates

    Thursday, May 17, 2018

    View article

  • Medicure Announces Normal Course Issuer Bid

    Thursday, May 17, 2018

    View article

  • Medicure Reports Financial Results for Quarter and Year Ended December 31, 2017

    Tuesday, May 1, 2018

    View article

  • Medicure announces availability of ZYPITAMAG™ (pitavastatin) in the U.S.

    Tuesday, May 1, 2018

    View article

  • Medicure to Announce Fiscal Year End 2017 Financial Results on April 30, 2018

    Tuesday, April 24, 2018

    View article

  • Medicure Announces Further Up-Date on PREXXARTAN®

    Wednesday, March 28, 2018

    View article

  • Medicure Announces an Up-Date on PREXXARTAN® Launch

    Monday, March 19, 2018

    View article

  • Zydus partners with Medicure to launch its NDA Product, ZYPITAMAG (pitavastatin) in the U.S.

    Wednesday, March 7, 2018

    View article

  • Medicure Announces Receipt of Deferred Proceeds from Apicore Sale

    Thursday, February 1, 2018

    View article

Unite Interactive